Development of the quadrivalent live attenuated influenza vaccine including two influenza B lineages – Victoria and Yamagata
This work is devoted to the research of the live attenuated influenza vaccine (LAIV) comprising two reassortant B/USSR/60/69-based vaccine influenza viruses Victoria and Yamagata. the intranasal immunization of the CBA mice with both victoria and yamagata strains induced 100% lung protection against...
Main Authors: | Yu. A. Desheva, T. A. Smolonogina, E. M. Doroshenko, L. G. Rudenko |
---|---|
Format: | Article |
Language: | English |
Published: |
Central Research Institute for Epidemiology
2016-02-01
|
Series: | Вопросы вирусологии |
Subjects: | |
Online Access: | https://virusjour.crie.ru/jour/article/viewFile/298/176 |
Similar Items
-
Study of Neuraminidase-Inhibiting Antibodies in Clinical Trials of Live Influenza Vaccines
by: Yulia Desheva, et al.
Published: (2020-05-01) -
Study of Antibodies to Influenza Neuraminidase N2
by: Yulia Desheva, et al.
Published: (2022-04-01) -
Quadrivalent inactivated influenza vaccine (VaxigripTetra™)
by: Viviane Gresset-Bourgeois, et al.
Published: (2018-01-01) -
A New Master Donor Virus for the Development of Live-Attenuated Influenza B Virus Vaccines
by: Chantelle L. White, et al.
Published: (2021-06-01) -
Novel Approaches for The Development of Live Attenuated Influenza Vaccines
by: Pilar Blanco-Lobo, et al.
Published: (2019-02-01)